Immunogenicity of Monovalent mRNA-1273 and BNT162b2 Vaccines in Children <5 Years of Age

The messenger RNA (mRNA)-based coronavirus disease 2019 vaccines approved for use in children

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatrics (Evanston) 2024-06, Vol.153 (6), p.1
Hauptverfasser:	Dalapati, Trisha, Williams, Caitlin A, Giorgi, Elena E, Hurst, Jillian H, Herbek, Savannah, Chen, Jui-Lin, Kosman, Christina, Rotta, Alexandre T, Turner, Nicholas A, Pulido, Natalie, Aquino, Jhoanna N, Pfeiffer, Trevor S, Rodriguez, Javier, Fouda, Genevieve G, Permar, Sallie R, Kelly, Matthew S
Format:	Artikel
Sprache:	eng
Schlagworte:	2019-nCoV Vaccine mRNA-1273 - immunology Age Antibodies Antibodies, Neutralizing - blood Antibodies, Viral - blood BNT162 Vaccine - administration & dosage BNT162 Vaccine - immunology Child, Preschool Children Cohort Studies Coronaviruses COVID-19 COVID-19 - immunology COVID-19 - prevention & control COVID-19 Vaccines - administration & dosage COVID-19 Vaccines - immunology Female Humans Immune response (humoral) Immunization Immunogenicity Immunogenicity, Vaccine - immunology Infant Male mRNA Prospective Studies SARS-CoV-2 - immunology Severe acute respiratory syndrome coronavirus 2 Spike Glycoprotein, Coronavirus - immunology Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The messenger RNA (mRNA)-based coronavirus disease 2019 vaccines approved for use in children
ISSN:	0031-4005 1098-4275 1098-4275
DOI:	10.1542/peds.2024-066190